Petwealth Uses AI to Turn Pet Lab Results Into Action

Angelo Palivos founded Petwealth after experiencing the disappointment of losing his own pet to an illness that a diagnostic lab had failed to detect in time. The company's mission is to bring veterinary care into the digital age by combining at-home molecular diagnostics with AI-driven reporting and telehealth services. Petwealth's approach aims to transition pet care from an emergency reactive model to a continuous, proactive monitoring system.

During the pandemic, pet owners grew comfortable with at-home testing, making it a feasible foundation for Petwealth's services. The company harnesses AI to transform raw PCR data into actionable reports that pet owners and veterinarians can utilize. By owning its lab infrastructure and automating report generation through AI, Petwealth reduces costs, making its diagnostics more accessible over time.

This infrastructure also enables strategic partnerships with telehealth platforms and veterinary software providers, extending Petwealth's reach beyond its internal capabilities. The company plans to leverage its longitudinal dataset of pet health outcomes to attract pharmaceutical companies looking for data to expedite the approval of animal health products, while also providing real-time insights to improve pet health outcomes.

Despite its reliance on AI, Petwealth's unique value lies in the combination of advanced technology with human expertise, creating a moat that protects the company from competitors.